Doctors Without Borders/Médecins Sans Frontières (MSF) calls on the pharmaceutical corporation ViiV to immediately provide transparency on the current available volume and planned geographic distribution of the HIV prevention medicine long-acting cabotegravir (CAB-LA) in order to urgently expedite the drug’s access for people in high-HIV-burden low- and middle-income countries (LMICs), where it could have the biggest [...]Read More... from Pharmaceutical corporation ViiV must improve it...
